Publication | Open Access

Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial)

Percutaneous Coronary InterventionCardiovascular DiseaseUnfractionated HeparinSurgeryReduce TrialMulticenter TrialMedicineAnticoagulantCardiologyHeparinsCoronary Artery Disease